RxDoctor Payments Data

Mamdouh Khayat, MD

Vascular & Interventional Radiology · Columbus, OHNPI 1780941583

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.6%), other and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Boston Scientific at 54.8% of the total. Reporting peaked in 2022 at $74,359 and has fallen 78.7% since, to $15,840 in 2025. Among vascular & interventional radiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$158,742in general payments, 2019–2025

Across 199 payments — averaging $797.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$87K
  • Angiodynamics, Inc.$69K
  • Inari Medical, Inc.$717
  • Nevro Corp.$465
  • Globus Medical$341
  • W. L. Gore & Associates, Inc.$308
  • plus $891 from 12 others

What the payments were for

  • Consulting fees$3,6882%
  • Speaking & faculty fees$69,27544%
  • Travel & lodging$11,4477%
  • Food & beverage$6,4164%
  • Other$67,91743%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$158,742 in reported general payments places this provider in the 95th percentile of 125 vascular & interventional radiology providers in Ohio.

See all vascular & interventional radiology providers in Ohio

Medicare billing

Part B allowed, 2024
$868,071
Medicare patients
268
Services billed
16,311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate78$307
Methylprednisolone45$233
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim47$175
Ibuprofen21$63
Famotidine34$35
IbuIbuprofen14$20

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →